Home » FDA Joins Nanotechnology Development Collaboration
FDA Joins Nanotechnology Development Collaboration
September 14, 2006
The FDA announced in late August it has entered into a three-year agreement with two national institutions to facilitate the development and regulation of nanotechnologies for research and cancer treatments, but one critic asserts the agency also needs to take similar actions for over-the-counter (OTC) products.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor